An intra-aortic balloon pump (IABP) is a temporary heart-assist device that helps a weakened heart pump blood more effectively. It consists of a thin catheter with an inflatable balloon at the tip, threaded through an artery and positioned inside the aorta, the body’s largest blood vessel. The balloon inflates and deflates in sync with each heartbeat, boosting blood flow to the heart and reducing the workload on a struggling heart muscle.
How the Device Works
The balloon sits in the descending aorta, just below where the blood vessels branch off to the head and arms. It’s made of polyurethane and holds between 25 and 50 milliliters of helium gas (smaller versions exist for children). An external console, connected to the balloon by the catheter, controls the timing of inflation and deflation.
The key to the device is its rhythm. The balloon inflates the instant the heart relaxes between beats. This pushes blood forward through the aorta and, critically, backward toward the heart’s own arteries, giving the heart muscle more oxygen-rich blood exactly when it needs it. Then, just before the heart contracts again, the balloon rapidly deflates. This creates a brief drop in pressure inside the aorta, making it easier for the heart to push blood out. The net effect: the heart gets more fuel and has to work less hard with every beat.
Helium is the gas of choice because its low density allows extremely fast inflation and deflation cycles. If the balloon were to rupture, helium dissolves quickly into the bloodstream, minimizing harm. The balloon does lose small amounts of gas over time through diffusion and needs periodic refilling by the console.
When It’s Used
The most common reason for placing an IABP is cardiogenic shock, a life-threatening condition where the heart suddenly can’t pump enough blood to meet the body’s needs. This often happens after a major heart attack. Other situations include supporting the heart after surgery, stabilizing patients with severe heart muscle disease (cardiomyopathy), and providing a bridge while waiting for a more permanent solution like a transplant or a longer-term assist device.
IABPs are also placed preventively in high-risk patients before coronary stenting procedures or cardiac surgery, where the heart may need extra support to get through the procedure safely. A study in the Journal of Clinical Medicine found that prophylactic IABP placement reduced heart muscle injury during high-risk stenting in patients with heart failure and borderline blood pressure.
It’s worth noting that the evidence for IABP use in cardiogenic shock has been debated. The landmark IABP-SHOCK II trial, published in the New England Journal of Medicine, found that adding an IABP to standard care (including reopening blocked arteries) did not significantly reduce 30-day mortality. About 40% of patients died in both the IABP group and the control group. There were also no meaningful differences in how quickly patients stabilized, how long they stayed in intensive care, or how well their kidneys functioned. This trial shifted guidelines, and the device is now used more selectively in shock patients rather than as a default.
Who Cannot Receive One
Certain conditions make IABP placement dangerous. A leaky aortic valve (moderate to severe aortic regurgitation) is one absolute rule-out, because the balloon’s pressure boost during the heart’s resting phase would force even more blood backward through the faulty valve, overloading the heart. Aortic dissection, a tear in the wall of the aorta, is another, since the balloon could worsen or extend the tear. Severe peripheral artery disease can make it impossible to safely thread the catheter through narrowed leg arteries. Uncontrolled bleeding disorders also rule out placement, given the risk of hemorrhage at the insertion site.
How It’s Inserted
The procedure typically takes place in a cardiac catheterization lab or intensive care unit. The patient lies flat, and the catheter is inserted through the common femoral artery in the groin using a technique called the Seldinger method: a needle punctures the artery, a thin guidewire is threaded through, and the catheter slides over the wire into position.
The balloon tip needs to land in a very specific spot: about 2 to 3 centimeters below where the left subclavian artery branches off the aorta. Too high and it could block blood flow to the left arm and brain. Too low and it won’t work as effectively and could block blood flow to the kidneys or gut. Doctors confirm placement using chest X-rays, looking for the aortic knob (the curved silhouette of the aortic arch) or the carina (the point where the windpipe splits into two bronchial tubes) as reference landmarks.
In some cases, particularly for patients awaiting heart transplant who need to stay mobile, the balloon can be inserted through an artery near the shoulder (the axillary artery) instead. This approach allows patients to sit up and walk, starting as early as the first day after placement. Research has shown that axillary insertion also carries a lower infection risk compared to the groin route, making it a strong option for patients who need support for days or weeks.
What Recovery Looks Like
While the IABP is in place through the femoral artery, you’ll need to lie flat on your back. The leg on the insertion side must stay relatively still to prevent the catheter from shifting or the artery from bleeding. Nursing staff monitor the pulses in your feet every hour to make sure blood flow to the leg isn’t compromised, and they watch the insertion site closely for signs of bleeding or infection.
The device typically stays in for a few days, though the duration depends entirely on how the heart responds. Before removal, doctors gradually reduce the level of support in a process called weaning. The balloon normally inflates with every heartbeat (a 1:1 ratio). During weaning, it’s dialed down to inflate every other beat (1:2), then every fourth beat (1:4), while the medical team watches for signs that the heart can handle the workload on its own. They track blood pressure, heart rate, blood lactate levels (a marker of whether tissues are getting enough oxygen), and ultrasound images of the heart’s pumping strength. If the heart remains stable at minimal support, the device is removed.
There are no universal, standardized weaning protocols. Teams rely on a combination of clinical judgment and the patient’s individual response, looking at hemodynamic stability, mental alertness, urine output, and whether extremities stay warm, all signs that blood is circulating adequately without heavy device support.
Risks and Complications
Major complications are relatively uncommon but real. Data from a large Canadian hospital found that limb ischemia (reduced blood flow to the leg) occurred in about 3% of patients. This happens because the catheter partially blocks the femoral artery. Bleeding at the insertion site occurred in roughly 1.6% of cases. Rarer complications included reduced blood flow to the intestines (0.5%) and compartment syndrome in the leg (0.5%), which sometimes required surgical intervention.
The risk of limb problems is one reason nurses check foot pulses so frequently. If the leg becomes cool, pale, or painful, the team can reposition or remove the device before permanent damage occurs. Patients with pre-existing artery disease in their legs face higher complication risks, which is part of why severe peripheral artery disease is a contraindication.
Blood cell damage is another concern. The mechanical action of the balloon can damage red blood cells and platelets as they pass over the inflating and deflating surface. Blood counts are monitored regularly throughout use.
Where It Fits Among Heart-Assist Devices
The IABP is the simplest and least invasive of the mechanical heart-support devices available. It provides modest assistance, generally boosting the heart’s output by about 0.5 liters per minute. For patients in mild to moderate trouble, that can be enough. For those in deeper shock, more powerful devices that actively pump blood (rather than just augmenting the heart’s own pumping) may be needed. The IABP remains widely used because it’s quick to place, relatively low-risk, and available at most hospitals with cardiac care capabilities.